NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8(+) T Cell Distribution in TME

Xia, L; Wang, H; Dong, H; Wang, Y; Lu, S

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (3): S567